| 0.185 Data as of May 16 |  0.00 / 0.00%Today’s Change | 0.00 Today|||52-Week Range 0.95 | +85.00% Year-to-Date |
| Previous close | 0.19 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 691 |
| Market cap | $4.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +92.22% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 0.1 |
| Price/Sales | -- |
| Price/Book | 0.43 |
| Today’s change | Today’s % change | |
|---|---|---|
| CADXCadence Pharmaceutic... | -0.06 | -0.86% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$356.5K |
| Net profit margin | -- |
Sector Consumer Services |
Industry Broadcasting |
Director, Chief Executive & Financial Officer Christopher Patrick Smith |
Corporate headquarters Orlando, Florida |
.
